Veterinary Medicine Information website

Metaxx 20 mg/ml solution for injection for cattle, pigs and horses

Authorised
  • Meloxicam
Download as PDF

Product identification

Medicine name:
Metaxx 20 mg/ml solution for injection for cattle, pigs and horses
Active substance:
  • Meloxicam
Target species:
  • Cattle
  • Horse
  • Pig
Route of administration:
  • Subcutaneous use
  • Intravenous use
  • Intramuscular use

Product details

Active substance and strength:
  • Meloxicam
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Concentrate for solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        15
        day
      • Milk
        120
        hour
  • Intravenous use
    • Cattle
      • Meat and offal
        15
        day
      • Milk
        120
        hour
    • Horse
      • Meat and offal
        5
        day
  • Intramuscular use
    • Pig
      • Meat and offal
        5
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AC06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • Colourless glass (Type I) injection vial closed with a bromobutyl rubber stopper and sealed with an aluminium cap. Cardboard box of 1 vial of 250 ml
  • Colourless glass (Type I) injection vial closed with a bromobutyl rubber stopper and sealed with an aluminium cap. Cardboard box of 1 vial of 100 ml
  • Colourless glass (Type I) injection vial closed with a bromobutyl rubber stopper and sealed with an aluminium cap. Cardboard box of 1 vial of 50 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic (abridged application) - art 13(1)
Marketing authorisation holder:
  • Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfasan Nederland B.V.
  • Produlab Pharma B.V.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V661177
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0376/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/05/2023
Download
French (PDF)
Published on: 22/05/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/05/2023
Download
German (PDF)
Published on: 22/05/2023
Download
French (PDF)
Published on: 22/05/2023
Download

Combined File of all Documents

English (PDF)
Published on: 8/05/2025
Download